Pablo
Irimia Sieira
Consultor Médico
Hospital Universitario La Fe
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Fe (8)
2024
-
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis
Journal of Headache and Pain, Vol. 25, Núm. 1
-
Nueva era terapéutica para el ataque de migraña con los recientemente aprobados anticuerpos monoclonales, ditanes y gepantes
Revista de neurologia, Vol. 78, Núm. 2, pp. 47-57
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
2022
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
2014
2009
-
Recommendations for the Use of Transcranial Doppler Ultrasonography to Determine the Existence of Cerebral Circulatory Arrest as Diagnostic Support for Brain Death
Reviews in the Neurosciences, Vol. 20, Núm. 3-4, pp. 251-260